PlainDoctor

2026 NPPES data Medical Oncology Physician NPI 1740302850 M.D.
Verify on CMS →

Daniel Lebovic, M.D.

Medical Oncology Physician in Grosse Pointe Woods, Michigan.

This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 3,792 in Medical Oncology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.

Federal data, no proprietary rating. We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
2K
Medicare Part D claims · 217 beneficiaries · Medical Oncology Physician avg: 689
Generic prescribing
61%
generic claims · 39% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
83.4/100
▲ 0 pts above national avg 83.1 · Above neutral
Industry payments
$23.9K
19 payments · CMS Open Payments (Sunshine Act)
Verify NPI on CMS Methodology
Compiled from official public sources by the PlainDoctor editorial team.

What the federal data shows

Daniel Lebovic, M.D. reported a CMS MIPS final score of 83.4/100 - above the 83.1 national average - and filed 1,705 Medicare Part D claims in 2023.

83.4/100
MIPS score · +0 vs avg
2K
Part D claims, 2023
61%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.

Daniel Lebovic, M.D.'s MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure

83 42nd percentile higher than 42% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). This entry sits in this band. 90+: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Where Daniel Lebovic, M.D. sits

This provider among medical oncology physician peers

Across the 1,527 medical oncology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Daniel Lebovic, M.D. writes more Part D claims than 89% of them and scores higher on MIPS quality than 42% - placing this provider in the high-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.

Part D claim volume vs MIPS quality, by specialty percentile

Lower volume · High qualityHigh volume · High qualityLower volume · Lower qualityHigh volume · Lower quality02550751000255075100Part D claim volume, percentile in specialtyMIPS quality, percentilePart D claim volume, percentile in specialty: 82 · MIPS quality, percentile: 50Part D claim volume, percentile in specialty: 0 · MIPS quality, percentile: 10Part D claim volume, percentile in specialty: 58 · MIPS quality, percentile: 17Part D claim volume, percentile in specialty: 8 · MIPS quality, percentile: 22Part D claim volume, percentile in specialty: 2 · MIPS quality, percentile: 40Part D claim volume, percentile in specialty: 80 · MIPS quality, percentile: 10Part D claim volume, percentile in specialty: 57 · MIPS quality, percentile: 17Part D claim volume, percentile in specialty: 22 · MIPS quality, percentile: 27Part D claim volume, percentile in specialty: 67 · MIPS quality, percentile: 42Part D claim volume, percentile in specialty: 23 · MIPS quality, percentile: 87Part D claim volume, percentile in specialty: 12 · MIPS quality, percentile: 15Part D claim volume, percentile in specialty: 27 · MIPS quality, percentile: 42Part D claim volume, percentile in specialty: 10 · MIPS quality, percentile: 70Part D claim volume, percentile in specialty: 48 · MIPS quality, percentile: 70Part D claim volume, percentile in specialty: 98 · MIPS quality, percentile: 97Part D claim volume, percentile in specialty: 60 · MIPS quality, percentile: 97Part D claim volume, percentile in specialty: 48 · MIPS quality, percentile: 37Part D claim volume, percentile in specialty: 73 · MIPS quality, percentile: 78Part D claim volume, percentile in specialty: 35 · MIPS quality, percentile: 10Part D claim volume, percentile in specialty: 53 · MIPS quality, percentile: 60Part D claim volume, percentile in specialty: 37 · MIPS quality, percentile: 70Part D claim volume, percentile in specialty: 17 · MIPS quality, percentile: 5Part D claim volume, percentile in specialty: 88 · MIPS quality, percentile: 0Part D claim volume, percentile in specialty: 18 · MIPS quality, percentile: 38Part D claim volume, percentile in specialty: 13 · MIPS quality, percentile: 2Part D claim volume, percentile in specialty: 45 · MIPS quality, percentile: 27Part D claim volume, percentile in specialty: 93 · MIPS quality, percentile: 27Part D claim volume, percentile in specialty: 87 · MIPS quality, percentile: 63Part D claim volume, percentile in specialty: 92 · MIPS quality, percentile: 75Part D claim volume, percentile in specialty: 75 · MIPS quality, percentile: 97Part D claim volume, percentile in specialty: 97 · MIPS quality, percentile: 93Part D claim volume, percentile in specialty: 7 · MIPS quality, percentile: 83Part D claim volume, percentile in specialty: 68 · MIPS quality, percentile: 58Part D claim volume, percentile in specialty: 28 · MIPS quality, percentile: 83Part D claim volume, percentile in specialty: 63 · MIPS quality, percentile: 42Part D claim volume, percentile in specialty: 25 · MIPS quality, percentile: 57Part D claim volume, percentile in specialty: 65 · MIPS quality, percentile: 88Part D claim volume, percentile in specialty: 40 · MIPS quality, percentile: 63Part D claim volume, percentile in specialty: 32 · MIPS quality, percentile: 22Part D claim volume, percentile in specialty: 62 · MIPS quality, percentile: 55Part D claim volume, percentile in specialty: 3 · MIPS quality, percentile: 82Part D claim volume, percentile in specialty: 30 · MIPS quality, percentile: 88Part D claim volume, percentile in specialty: 78 · MIPS quality, percentile: 53Part D claim volume, percentile in specialty: 100 · MIPS quality, percentile: 27Part D claim volume, percentile in specialty: 83 · MIPS quality, percentile: 92Part D claim volume, percentile in specialty: 55 · MIPS quality, percentile: 17Part D claim volume, percentile in specialty: 47 · MIPS quality, percentile: 80Part D claim volume, percentile in specialty: 95 · MIPS quality, percentile: 3Part D claim volume, percentile in specialty: 70 · MIPS quality, percentile: 48Part D claim volume, percentile in specialty: 52 · MIPS quality, percentile: 47Part D claim volume, percentile in specialty: 42 · MIPS quality, percentile: 27Part D claim volume, percentile in specialty: 90 · MIPS quality, percentile: 77Part D claim volume, percentile in specialty: 33 · MIPS quality, percentile: 95Part D claim volume, percentile in specialty: 5 · MIPS quality, percentile: 5Part D claim volume, percentile in specialty: 38 · MIPS quality, percentile: 63Part D claim volume, percentile in specialty: 15 · MIPS quality, percentile: 60Part D claim volume, percentile in specialty: 72 · MIPS quality, percentile: 63Part D claim volume, percentile in specialty: 43 · MIPS quality, percentile: 25Part D claim volume, percentile in specialty: 20 · MIPS quality, percentile: 8Part D claim volume, percentile in specialty: 77 · MIPS quality, percentile: 27Daniel Lebovic, M.D.-Part D claim volume, percentile in specialty: 89 · MIPS quality, percentile: 42
Part D claim volume vs MIPS quality, by specialty percentile

Each dot is one medical oncology physician peer from a representative sample of 60; the gold marker is Daniel Lebovic, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.

✓
Board certification likely (heuristic, not verified)

Daniel Lebovic, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about Daniel Lebovic, M.D.?

Near national average

NPI registry status

Active

Issued 04/06/2007

NPI 1740302850

Primary specialty

Medical Oncology Physician

Niche

3,792 US NPIs in this specialty

Medicare Part D claims

1,705 147% vs specialty avg

2023 prescription claims

Specialty avg: 689

MIPS final score

83.4/100 0.3 pts vs avg

Above neutral band

vs 83.1 national avg

Specialty distribution in Michigan

How Medical Oncology Physician compares to other specialties among Michigan providers

Michigan providers
Behavior Technician - 21.4%Behavior Technician21.4%Clinical Social Worker - 5.8%Clinical Social Worker5.8%Student in an Organized Health Care Education/Training Program - 3.6%Student in an Organized Health Care Education/Training Program3.6%Physical Therapist - 3.4%Physical Therapist3.4%Social Worker - 3.4%Social Worker3.4%Pharmacist - 3%Pharmacist3%Medical Oncology Physician - 0%Medical Oncology Physician0%
Largest specialties in Michigan (% of in-state providers)

Medicare quality performance, MIPS

Daniel Lebovic, M.D.'s 2023 MIPS final score plotted against the Medical Oncology Physician national average

Near national average
MIPS Final Score
83.4/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Medical Oncology Physician) - 83.4/100 vs national avg 83.1

0%100%National avg83%83.4%
MIPS final score (Medical Oncology Physician) - 83.4/100 vs national avg 83.1
How MIPS and board certification work

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

Daniel Lebovic, M.D. appears in the CMS NPPES registry as a Medical Oncology Physician provider holding M.D. credentials at 19229 MACK AVE, Grosse Pointe Woods, MI, 48236, with a listed phone of (313) 884-5522. NPI 1740302850 was issued on 04/06/2007.

Medicare Part D records for calendar year 2023 show 1,705 prescription claims written by this provider, covering 217 Medicare beneficiaries and totaling roughly $8.8 million in drug spend, split 39% brand-name and 61% generic by claim count, with an opioid prescribing rate of 1.8%. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 83.4/100 for the 2023 performance year (Quality 68.1, Cost 60.6), compared with the national average of 83.1.

Medical Oncology Physician is a narrow specialty nationwide, with 3,792 enrolled providers across 53 states and an average of 689 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.

Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

19229 MACK AVE
Grosse Pointe Woods, MI 48236
(313) 884-5522

Provider Details

NPI 1740302850
Specialty Medical Oncology Physician
Credentials M.D.
Gender Male
NPI Issued 04/06/2007

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

83.357
Final Score
Avg: 83.1
68.0602
Quality
60.6155
Cost
100
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where Daniel Lebovic, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

Henry Ford Health St John Hospital
★☆☆☆☆ 1/5
Grosse Pointe Woods, MI
Acute Care Hospitals
CMS CCN: 230165

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) - CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Daniel Lebovic, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$23.9K

Largest payer

GENZYME CORPORATION

Most common payment type

Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program

Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context - Michigan MI-BOM 2023 annual report

Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~41K Michigan medical licensees in 2023 - they are NOT specific to Daniel Lebovic, M.D.. To verify Daniel Lebovic, M.D.'s current license status, search the MI-BOM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

123
Total board actions, Michigan 2023
Across 120 cases
3.00
Actions per 1,000 licensees
Michigan statewide rate
probation
Most common action type
44 cases

MI-BOM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Michigan disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

Daniel Lebovic, M.D. - brand share 39.0%
Medical Oncology Physician average

39% brand-name claims vs 61% generic, on 1,705 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

1,705
Total Claims
$8.8M
Total Drug Cost
217
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
2,308
Total Day Supply
66,481
Brand vs Generic
39% brand / 61% generic
Brand Drug Cost
$7.4M
Generic Drug Cost
$1.4M
Opioid Claims
30 (1.8% rate)
Antibiotic Claims
59

Patient Demographics

Average Patient Age
72.6 years
Avg HCC Risk Score
2.44
Gender Split
60% female / 40% male
Age Distribution
<65: 32, 65-74: 87, 75-84: 68, 85+: 30

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What Daniel Lebovic, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Hydroxyurea
 178
Acyclovir
 148
Revlimid
Lenalidomide
147
Eliquis
Apixaban
102
Jakafi
Ruxolitinib Phosphate
94
Lenalidomide
 85
Dexamethasone
 64
Imbruvica
Ibrutinib
63
Warfarin Sodium
 55
Potassium Chloride
 47

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

More Medical Oncology Physician in MI → All providers in Michigan → Compare specialties →

Medical Oncology Physician Overview

How Daniel Lebovic, M.D. fits within the Medical Oncology Physician landscape nationally.

3,792
Medical Oncology Physician Providers in US
53
States with Medical Oncology Physician
689
Avg Claims per Provider

Daniel Lebovic, M.D.'s 1,705 claims are above the specialty average of 689.

Nearby Medical Oncology Physician Providers in Michigan

Other clinicians with the same primary specialty enrolled in Michigan, drawn from the same CMS NPPES roster as Lebovic.

Dr. Eugene Agnone
M.D.
Roseville, MI
Dr. Muhammad Ahmed
M.D.
Three Rivers, MI
Dr. Adil Akhtar
M.D.
Sterling Heights, MI
Dr. Ayham Al Ashkar
MD
Royal Oak, MI
Dr. Kathryn Alguire
M.D.
Norton Shores, MI

Compare Medical Oncology Physician nationally: see state-by-state distribution →

Before you book an appointment

Use this federal record as your verification checklist, not as a recommendation.

  • Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
  • Check the active license and any disciplinary history with the Michigan medical board, federal registration is not a license check. Credential verification guide
  • Weigh a second option: compare this provider with a nearby Medical Oncology Physician peer on Medicare volume and prescribing patterns. Compare providers

Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.

Healthcare Guides

Learn more about finding, verifying, and understanding healthcare providers.

How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026

Explore Michigan

Providers in Michigan
Browse all specialties and cities
All Specialties
690+ healthcare specialties
Rankings
Top prescribers and providers by state

Frequently Asked Questions

What is Daniel Lebovic, M.D.'s specialty? ▼
Daniel Lebovic, M.D. specializes in Medical Oncology Physician and practices in Grosse Pointe Woods, Michigan. Credentials: M.D..
How much does Daniel Lebovic, M.D. prescribe under Medicare Part D? ▼
In 2023, Daniel Lebovic, M.D. wrote 1,705 Medicare Part D claims totaling $8.8M in drug costs for 217 beneficiaries.
What is Daniel Lebovic, M.D.'s Medicare quality score? ▼
Daniel Lebovic, M.D. has a CMS MIPS Final Score of 83.4/100 (Quality: 68.1, Cost: 60.6). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Daniel Lebovic, M.D. located? ▼
Daniel Lebovic, M.D. is located at 19229 MACK AVE, Grosse Pointe Woods, MI, 48236. Phone: (313) 884-5522.
What is Daniel Lebovic, M.D.'s NPI number? ▼
Daniel Lebovic, M.D.'s National Provider Identifier (NPI) is 1740302850, issued on 04/06/2007.
Does Daniel Lebovic, M.D. prescribe more brand-name or generic drugs? ▼
Daniel Lebovic, M.D.'s prescribing is 39% brand-name and 61% generic drugs by claim count, with $7.4M in brand drug costs.
Does Daniel Lebovic, M.D. prescribe opioids? ▼
Yes, Daniel Lebovic, M.D. had 30 opioid claims in 2023 with an opioid prescribing rate of 1.8%.
How many Medical Oncology Physician providers are there in the US? ▼
There are 3,792 Medical Oncology Physician providers across 53 states in the US. The average Medical Oncology Physician provider writes 689 Medicare Part D claims per year.
What drugs does Daniel Lebovic, M.D. prescribe most often? ▼
Based on 2023 Medicare Part D data, Daniel Lebovic, M.D.'s most frequently prescribed drugs include Hydroxyurea, Acyclovir, Revlimid. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Daniel Lebovic, M.D. accept Medicare? ▼
Daniel Lebovic, M.D. appears in CMS Medicare data with 1,705 Part D claims and 217 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Daniel Lebovic, M.D.'s credentials? ▼
Daniel Lebovic, M.D.'s NPI is 1740302850 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

View source datasets and methodology notes
Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology

Compiled from official public sources by the PlainDoctor editorial team.